GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Inventories, Inventories Adjustments

Cessatech AS (XSAT:CESSA) Inventories, Inventories Adjustments : kr0.00 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cessatech AS Inventories, Inventories Adjustments?

Cessatech AS's Inventories, Inventories Adjustments for the quarter that ended in Mar. 2024 was kr0.00 Mil.


Cessatech AS Inventories, Inventories Adjustments Historical Data

The historical data trend for Cessatech AS's Inventories, Inventories Adjustments can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cessatech AS Inventories, Inventories Adjustments Chart

Cessatech AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Inventories, Inventories Adjustments
- - - -

Cessatech AS Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Inventories, Inventories Adjustments Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cessatech AS Inventories, Inventories Adjustments Calculation

Inventories, Inventories Adjustments represents certain charges made in the current period in inventory resulting from breakage, spoilage, employee theft and shoplifting, etc.


Cessatech AS (XSAT:CESSA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cessatech AS (XSAT:CESSA) » Definitions » Inventories, Inventories Adjustments
Traded in Other Exchanges
Address
Kanonbadsvej 2, Copenhagen, DNK, 1437
Cessatech AS is a pharmaceutical company committed to developing and commercializing evidence-based and innovative medicines for children for the treatment of paediatric acute pain. Its lead asset (CT001) is an analgesic nasal spray for the treatment of acute and planned painful procedures in children.

Cessatech AS (XSAT:CESSA) Headlines

No Headlines